Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia

Trial Profile

Rollover Study for Continuing Valbenazine (NBI-98854) Administration for the Treatment of Tardive Dyskinesia

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 08 Sep 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Valbenazine (Primary)
  • Indications Drug-induced dyskinesia
  • Focus Adverse reactions
  • Sponsors Neurocrine Biosciences
  • Most Recent Events

    • 03 Sep 2020 According to a Neurocrine Biosciences media release, data from this trial will be presented at the upcoming virtual scientific meetings, 2020 Psych Congress on September 10 to 13 and the MDS Virtual Congress 2020 on September 12 to 16
    • 15 Aug 2018 According to a Neurocrine Biosciences media release, data will be presented at the 2018 World Congress on Parkinson's Disease and Related Disorders(IAPRD) .
    • 03 Aug 2017 Status changed from recruiting to completed, according to a Neurocrine Biosciences media release.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top